SAMSUNG PHARMACEUTICAL.CO.,Ltd. 001360

KRX · South Korea · Health Technology

KRW 1,433.00-31.00 (-2.12%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

SAMSUNG PHARMACEUTICAL.CO.,Ltd. 001360

KRX · South Korea · Health Technology

KRW 1,433.00-31.00 (-2.12%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-19.49% · 6MFull-screen chart

Open KRW 1,466.00High KRW 1,500.00Low KRW 1,410.00Close KRW 1,433.00Volume 721.08K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: KRW 1,464.00
Day range: KRW 1,410.00 – KRW 1,500.00
52-week range: KRW 1,140.00 – KRW 2,320.00
Volume: 721.08K
Market cap: KRW 137.79B
Avg. volume (1Y): 1.48M

Performance

1 week

+9.56%

1 month

+7.66%

3 months

+7.66%

6 months

-21.18%

Year to date

-7.55%

1 year

-10.44%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: South Korea
Exchange: KRX
Shares outstanding: 94.12M
Employees: 87
ISIN: KR7001360007
Beta: 0.37

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJan 19, 2026

CNP Global Reignites the K-Kids Red Ginseng Beverage Category in Vietnam

CNP Global Co., Ltd. is a specialized development and outsource manufacturing company that develops beverages for children for both domestic and international markets. Aligned with its corporate philosophy of "leading a healthy food culture," the company has built strong competitiveness in overseas export markets by adhering to Korea's rigorous quality control standards and maintaining a stable production system. In particular, CNP Global has earned a reputation for high credibility through year

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.